Oman to host World Cancer Congress
Published: 02:09 PM,Sep 16,2025 | EDITED : 06:09 PM,Sep 16,2025
The congress serves as a strategic platform to unite global efforts, focusing on prevention, capacity building, patient empowerment, and scientific research to drive tangible progress toward a healthier, more sustainable future.
Spanning four intensive days, the program features advanced scientific sessions, high-level policy summits, interactive community events, and practical workshops addressing critical topics such as healthcare innovations, public policies for cancer control, and community awareness. These elements position the congress not merely as a scientific gathering but as a dynamic platform for collective action to reduce cancer incidence and improve the quality of life for patients and survivors.
The event attracts a diverse group of professionals and stakeholders, ensuring its inclusivity and global impact. Attendees include oncologists, radiologists, pathologists, nurses, general practitioners, palliative care specialists, researchers, academics, policymakers, international organizations, civil society groups, cancer survivors, caregivers, and industry representatives from pharmaceuticals, biotechnology, health technologies, artificial intelligence, and healthcare financing. This diverse assembly fosters discussions on challenges and opportunities, emphasizing innovation and effective collaboration to address cancer comprehensively.
The summit focuses on forging sustainable strategic partnerships to combat cancer through in-depth discussions on prevention, healthcare workforce training, patient empowerment, and research support. The accompanying four-day exhibition showcases the latest innovations in pharmaceuticals, medical devices, digital health solutions, holistic wellness centers, nutritional supplements, and rehabilitation services. It offers exceptional opportunities for companies and organizations to present their products to global health leaders, fostering commercial and innovative networking.